"Medicare Part C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The Balanced Budget Act (BBA) of 1997 establishes a Medicare+Choice program under part C of Title XVIII, Section 4001, of the Social Security Act. Under this program, an eligible individual may elect to receive Medicare benefits through enrollment in a Medicare+Choice plan. Beneficiaries may choose to use private pay options, establish medical savings accounts, use managed care plans, or join provider-sponsored plans.
Descriptor ID |
D020398
|
MeSH Number(s) |
N03.219.521.346.506.564.663.757 N03.219.521.576.343.840.877 N03.706.615.420.249
|
Concept/Terms |
Medicare Part C- Medicare Part C
- Part C, Medicare
- Medicare+Choice Program (US)
- Medicare+Choice Programs (US)
- Program, Medicare+Choice (US)
- Programs, Medicare+Choice (US)
- Medicare Plus Choice Program (US)
- Medicare Choice
- Medicare Plus Choice
- Choice, Medicare Plus
- Plus Choice, Medicare
Medicare Advantage- Medicare Advantage
- Advantage, Medicare
- Advantages, Medicare
- Medicare Advantages
|
Below are MeSH descriptors whose meaning is more general than "Medicare Part C".
Below are MeSH descriptors whose meaning is more specific than "Medicare Part C".
This graph shows the total number of publications written about "Medicare Part C" by people in this website by year, and whether "Medicare Part C" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2016 | 2 | 1 | 3 |
2019 | 0 | 2 | 2 |
2020 | 2 | 1 | 3 |
2021 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
2023 | 4 | 0 | 4 |
2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Medicare Part C" by people in Profiles.
-
Group-based trajectory modeling to identify adherence patterns for direct oral anticoagulants in Medicare beneficiaries with atrial fibrillation: a real-world study on medication adherence. Int J Clin Pharm. 2024 Dec; 46(6):1525-1535.
-
Predictors of adherence to direct oral anticoagulants after cardiovascular or bleeding events in Medicare Advantage Plan enrollees with atrial fibrillation. J Manag Care Spec Pharm. 2024 May; 30(5):408-419.
-
Traditional Medicare or Medicare Advantage? The Leukemia and Cancer Perspective. Mayo Clin Proc. 2024 Jan; 99(1):15-21.
-
Trajectories of adherence to ACEI/ARB medications following a motivational interviewing intervention among Medicare Advantage beneficiaries in Texas. Patient Educ Couns. 2024 Feb; 119:108073.
-
Disparity in initiation of checkpoint inhibitors among commercially insured and Medicare Advantage patients with metastatic melanoma. J Manag Care Spec Pharm. 2023 Nov; 29(11):1232-1241.
-
A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes. Drugs Aging. 2023 04; 40(4):377-390.
-
Assessment of Unmet Health-Related Social Needs Among Patients With Mental Illness Enrolled in Medicare Advantage. JAMA Netw Open. 2022 11 01; 5(11):e2239855.
-
Evaluating perceptions of social determinants of health and Part D star performance of Medicare Advantage-contracted primary care providers serving a South Texas market. J Manag Care Spec Pharm. 2021 May; 27(5):544-553.
-
Risk of Cardiovascular Outcomes and Antihypertensive Triple Combination Therapy Among Elderly Patients with Hypertension Enrolled in a Medicare Advantage Plan (MAP). Am J Cardiovasc Drugs. 2020 Dec; 20(6):591-602.
-
Cost-effectiveness analysis of antihypertensive triple combination therapy among patients enrolled in a Medicare advantage plan. Expert Rev Pharmacoecon Outcomes Res. 2021 Aug; 21(4):829-836.